中国P站

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Opinion Article   
  • Clin Pharmacol Biopharm 14: 568.,

Nanocarriers Revolutionize Drug Delivery: Targeted, Responsive, Theranostic Systems

Dr. Fatima Zahra Khan*
Department of Biopharmaceutics, Zenith College of Pharmaceutical Research, Zenith University, Nova City, Pakistan
*Corresponding Author : Dr. Fatima Zahra Khan, Department of Biopharmaceutics, Zenith College of Pharmaceutical Research, Zenith University, Nova City, Pakistan, Email: fatima.khan@zenith.edu.pk

Abstract

Nanocarriers have transformed drug delivery by enhancing efficacy, solubility, and targeting while reducing toxicity. Recent advancements include stimuli-responsive systems for precise drug release. Key platforms like liposomes, polymeric nanoparticles, dendrimers, and lipid-based nanoparticles are under continuous development. Challenges in clinical translation persist, but progress is enabling wider application. Emerging areas include oral delivery, theranostics, and stimuli-responsive strategies for site-specific treatment.

Citation:

Copyright:

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 236
  • [From(publication date): 0-0 - Apr 07, 2026]
  • Breakdown by view type
  • HTML page views: 192
  • PDF downloads: 44
International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.